ATF4 and microcephaly: Administration of a PERK inhibitor was reported to correct cortical neurogenesis during ZIKV infection without affecting viral replication, suggesting that PERK and ATF4 activation may contribute to fetal microcephaly associated with congenital ZIKV infection [26].